Clinical Trials

60 enrolled

Esophageal Neoplasms

NCT07050043 2025-07-03

LEDANG

Phase 3 Recruiting

123 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06927180 2025-06-23

SHR-A1811 Plus Pertuzumab in the Neoadjuvant Treatment of HER2 Positive BC

180 enrolled

Pathologic Complete Response, Breast Neoplasms

NCT02446652 2025-05-29

Evaluation of TRANSKRIP ® Plus Chemotherapy in Recurrent-Persistent Cervical Cancer

Phase 3 Withdrawn

Gynecologic

Uterine Cervical Neoplasms

NCT06670911 2025-02-24

ACCESS-I

44 enrolled

Recurrence

NCT05475678 2025-01-23

Clinical Study of Camrelizumab Combined With TCb Versus TCb in Neoadjuvant Treatment of Triple-negative Breast Cancer

369 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06786312 2025-01-22

A Single-arm, Multicenter, Prospective Phase II Clinical Study of Apatinib in Combination With Adebrelimab and EC Regimen in the First-line Treatment of Extensive Small Cell Lung Cancer

34 enrolled

Small Cell Lung Carcinoma

NCT05628610 2024-08-13

Tislelizumab Combined With Chemotherapy or Radiotherapy in the Treatment of Advanced or Recurrent Metastatic Elderly Esophageal Cancer

130 enrolled

Esophageal Neoplasms

NCT05474690 2024-02-26

A Study Comparing the Efficacy of TCbHP and ECHP-THP in the Neoadjuvant Treatment of HER2-positive Breast Cancer

Phase 3 Withdrawn

Pathologic Complete Response, Breast Neoplasms

NCT05377658 2024-02-21

AK104 With Chemotherapy as Neoadjuvant and Adjuvant Therapy for Resectable Non-small Cell Lung Cancer

43 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06066216 2024-01-23

Cadonilimab (AK104) Plus Chemotherapy in Patients With Recurrent or Advanced Endometrial Cancer

Phase EARLY_PHASE1 Unknown

45 enrolled

Gynecologic

Endometrial Neoplasms

NCT06208033 2024-01-17

SMET12 and Toripalimab Combined Chemotherapy in Patients With EGFR Positive Advanced Non-small Cell Lung Cancer (NSCLC)

40 enrolled

EGFR Positive Non-small Cell Lung Cancer

NCT05832827 2023-10-23

Artemis

35 enrolled

Thymoma

NCT03735966 2022-12-01

Neoadjuvant Study of Pyrotinib and Trastuzumab Plus Docetaxel and Carboplatin in HER2 Positive Breast Cancer Patients.

Phase 2 Completed

75 enrolled

HER2 Positive Breast Cancer

NCT02860819 2021-03-03

Study of Gemcitabine, Carboplatin and VELIPARIB (ABT-888) in Refractory Testicular Germ Cell Cancer

Phase 2 Completed

15 enrolled

Genitourinary

Testicular Neoplasms

NCT02737774 2020-07-01

Alternating Icotinib and Chemotherapy for Advanced Non-small Cell Lung Cancer With EGFR Mutation

Phase 2 Unknown

60 enrolled

Adenocarcinoma of Lung

NCT03790228 2020-04-15

Anlotinib Combined With Pemetrexed And Carboplatin as First-line Treatment in Advanced Nonsquamous NSCLC

Phase 1 Unknown

43 enrolled

Non-squamous Cell Non-Small Cell Lung Cancer

NCT02741856 2018-10-25

SCOPE2

Phase 2/3 Unknown

584 enrolled

Esophageal Neoplasms

NCT02804646 2016-06-21

Endostar Durative Transfusion Combined With Chemotherapy in the Treatment of Advanced Lung Adenocarcinoma

Phase 4 Unknown

100 enrolled

Adenocarcinoma of Lung

NCT02738346 2016-04-25

CBPC

Phase 3 Unknown

164 enrolled

Small Cell Lung Carcinoma

NCT00697905 2014-11-21

Combination of Gemcitabine and Carboplatin in Metastatic or Recurrent Nasopharyngeal Carcinoma

Phase 2 Completed

18 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT01843829 2014-03-24

NeoSCOPE

Phase 2 Unknown

85 enrolled

Esophageal Neoplasms

NCT01836575 2013-04-22

PS2

Phase 3 Completed

228 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01654146 2012-07-31

ICON8

Phase 3 Unknown

1,485 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00563160 2010-07-07

Study of Efficacy of Induction Chemotherapy With Gemcitabine and Carboplatin for Operable Non-small-cell Lung Cancer Before Surgery

Phase 2 Unknown

50 enrolled